NA-831

· Biomed Industries, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NA-831, covering 2020-06-30 to 2022-02-16. Get the full timeline:

Most recent: Clinical Trial Update: NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection [Phase 2, Phase 3]

See pricing